Home » Tenders » Europe » Sweden » Contract notice: Pharmaceutical products Tender, Sweden - 24392184

Contract notice: Pharmaceutical products Tender, Sweden - 24392184

GÖTEBORGS UNIVERSITET has floated a tender for Contract notice: Pharmaceutical products. The project location is Sweden and the tender is closing on 27 Jul 2018. The tender notice number is 267554-2018, while the TOT Ref Number is 24392184. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Sweden

Summary : Contract notice: Pharmaceutical products

Deadline : 27 Jul 2018

Other Information

Notice Type : Tender

TOT Ref.No.: 24392184

Document Ref. No. : 267554-2018

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : GÖTEBORGS UNIVERSITET
Office Name: Göteborgs universitet
Address: Box 100
Town: Gothenburg
Postal Code: 405 30
Contact Point: Allem Tensaye

Sweden
Email :allem.tensaye@gu.se
URL :http://www.gu.se

Tender Details

Object of the contract
Pharmaceutical products

Description: Contract notice: Pharmaceutical products

Authority Type: Ministry or any other national or federal authority
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: The most economic tender
CPV code: 33600000, 73000000, 33600000, 73000000
CPV Description: Pharmaceutical products.

Research and development services and related consultancy services.

Manufacturing and delivery of study drugs

Reference Number: EUI 18 047

The Department of Psychiatry and Neuroscience at Goeteborg University will conduct a randomized, double-blind, placebo-controlled multicenter trial. Prior to the study a larger amount of study drug is required, approximately 138, 000 doses, -from two different drugs and placebo. A thorough pre-study prior to the study is that the doses can be randomized, blinded and blister packed to ensure that the patients and the feeders do not know what preparations have been taken.

The Department of Psychiatry and Neuroscience at Goeteborg University will conduct a randomized double blind placebo-controlled multicenetampering trial to investigate the varenicline (Champix (r)) and bupropion (Zyban (r)) bupropion (Zyban (r)) combination, or combination of alcohol consumption, in alcohol dependents.

About the procurement

The section before psychiatry and neurochemistry and physiology) at Goeteborg University will conduct a research study as below. Before the study kraevs and a larger mixed study drug, ca. 138, 000 doses, from two different drugs and placebo. A thorough pre-study prior to the study is that the doses can be randomized, blinded and blister packed prior to saekerstaella that patients and researchers have no clue about which preparations have been taken.

Brief information on the research study: A randomized, double-blind, placeborolled, 14-week, multicenter trial before examining two different antiviral drugs in combination or before decreasing alcohol consumption in alcohol-dependent individuals. More information about the manufacturing specification and the buyer's requirements can be found in section 3.

More information about the research study can be obtained from responsible project manager Helga Lidoe (helga.lido@neuro.gu.se, 46 709179311):

Visma ad: https://opic.com/id/afcgkyxlwl

Internet address (URL): http://www.gu.se
Directive: Classical Directive (2014/24/EU)